Explore the latest trends in HCP content consumption and how pharma marketers can adapt their strategies to reach their target audience effectively.

Stacia Garner, VP of marketing at Edwards Lifesciences, discusses the company’s partnership with the Los Angeles Rams to raise awareness of heart valve failure.

Pharma Editor Lecia Bushak spoke with Relevate Health’s Sam Glassenberg about its recent type 1 diabetes video game launch over the summer.

Cybin CEO Doug Drysdale talks with Pharma Editor Lecia Bushak about "second-generation" psychedelics and how they are impacting the mental health treatment space.

Christophe Hotermans, Alexion’s head of global medical affairs, discusses the drugmaker’s latest rare disease-focused film.

MM+M’s summer intern, Lola Offenback, says goodbye after eight strong weeks at the publication.

Currax’s Derrick Gastineau discusses the drugmaker’s recently-launched Real Patients, Real Results campaign and its position in the weight loss market.

ViiV Healthcare’s Dr. Alftan Dyson shares looming gaps in HIV education and awareness amongst Black communities, and how marketers can address this.

Shannon Langrand, CEO of her namesake agency, offers insights into how health insurers are being marketed in 2025 as well as what challenges are lingering in the payer space.

Noom CEO Geoff Cook and Chief Medical Officer Dr. Jeffrey Egler break down the company’s new Microdose GLP-1 program.

Breakthrough T1D leaders discuss collaborating with Mattel to create the first Barbie doll to feature a continuous glucose monitor and an insulin pump.

Former CMS leader Mark Newsom talks about making the jump to the world of medical marketing.

Andrew Schultz, president of PatientPoint Precision, and David Paragamian, CEO of Health Monitor Network, discuss the best ways to leverage POC marketing.

Professor Gökhan Hotamisligil, the James Stevens Simmons Professor of Genetics and Metabolism at Harvard Chan School, discusses the unique collaboration between his research team and İş Private Equity.

As media habits evolve and audiences fragment across screens, pharma marketers are reassessing where and how to show up. Traditional channels face increasing pressure, while new environments — particularly CTV, OTT, and premium video formats like cinema — are gaining ground for their ability to deliver both attention and measurable outcomes. This roundtable explores how pharma can realign its strategy to ensure visibility, resonance, and results in today’s shifting media ecosystem.

Reporter Heerea Rikhraj delves into the Cannes Lions-winning No More Hippocrites campaign with Eversana Intouch’s Ivan Blotta.

Dr. Julius Wilder, a gastroenterologist at Duke University joins the podcast to talk about “Steps Ahead,” a new documentary that highlights health inequality in Durham, North Carolina.

Pharma editor Lecia Bushak speaks with Regeneron exec Justin Holko about the top commercial and marketing trends in pharma.

In this special episode of the MM+M Podcast, we sit down with Dr. Osama Hashmi — dermatologist, cofounder and chief product officer at Impiricus — alongside practicing physician Dr. Ahmed — an interventional/structural cardiologist, cofounder and CSO of Lylah, a personalized microbiome therapeutics company — to explore how artificial intelligence is transforming the way healthcare professionals connect with pharmaceutical resources.